Marketresearchnews

Thursday, 29 October 2020

Dental Trauma Market to Witness an Outstanding Growth by 2023

Market Highlights

During last decade the number of procedures have increased which has influenced the growth of the market positively. Moreover, increasing demand for the better treatment and changing reimbursement policies has boosted the market growth.

Increasing number of patients suffering from different dental diseases have increased the demand different treatments in the market. During the last few years, the dental consumables have changed the treatment scenario. The market is expecting a healthy growth during the next decade. Moreover, well developed technology has supported the growth of the market in this region.

Browse Sample of the Report @ https://www.marketresearchfuture.com/sample_request/5301

According to the Pew Center on the States, in 2010, Americans spend USD 106 billion on dental care. According to the American Dental Association, in 2010, over 600 million dental procedures were performed which will continuously increase in coming future.

Approximately 75 % of all procedures were diagnostic procedures of which children aged 0–20 accounts for 41% of all procedures.

The global dental trauma market is expected to grow at a CAGR of ~8.6 % during the forecast period 2017-2023.

Regional Analysis

The Americas dominate the global dental trauma market owing to the presence of huge patient population with dental injuries, high healthcare spending, and increasing government support for research & development.

Europe holds the second largest dental trauma market share of the global market as result of increasing focus of various government agencies on the treatment of dental diseases. Moreover, the growing public awareness about dental trauma likely to boost the European market.

Asia Pacific is the fastest growing dental trauma market across the globe. Japan holds the major share of the regional market due to availability of advanced technology and huge healthcare spending. Moreover, rapidly developing economy, increasing healthcare expenditure, and the government’s initiatives for research & development projected to drive the market in China and India over the forecasted period.

The Middle East and Africa holds the least share of the global market due to limited availability of medical facilities. The UAE, Saudi Arabia, and Kuwait are expected to drive the Middle East & African market. Whereas, the African region is expected to witness a moderate growth.

Segmentation

The global dental trauma market is segmented on the basis of types, by treatment, and by end user. On the basis of type, it is segmented into tooth fracture, injuries of the periodontal apparatus, and injuries to supporting bone tissues. Tooth fracture is further segmented into enamel infraction, enamel fracture, enamel-dentine fracture, complex fracture of tooth, root fracture of tooth. Injuries of the periodontal apparatus is further segmented into subluxation of the tooth (tooth knocked loose), luxation of the tooth, intrusion of the tooth (tooth jammed into tooth socket), avulsion of the tooth. Injuries to supporting bone tissues is further segmented into fracture of mandibular/maxillary socket wall, fracture of mandibular/maxillary alveolar processes, fracture of mandible/maxilla. Based on the treatment, it is segmented into cosmetic dentistry, laser dentistry, and others. On the basis of end user, it is segmented into dental clinics, dental laboratories, research laboratories, and others.

Key Players

Some of key the players in the market are Patterson Dental (U.S.), Henry Schein (U.S.), Dentsply Sirona (U.S.), 3M (U.S.), Straumann (Switzerland), Danaher Corporation (Switzerland), PLANMECA OY (Finland), Carestream Health, Inc. (U.S.), Biolase Inc (U.S.), KERR Corporation (U.S.), GC orthodontics (Germany), American Orthodontics (U.S.), Zimmer Holdings Inc. (U.S.), Ivoclar Vivadent AG (Liechtenstein), Gentle Dentistry, LLC (U.S.) and others.

FOR MORE DETAILS – https://www.marketresearchfuture.com/reports/dental-trauma-market-5301

About US:

Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact Us:

Market Research Future

Office No. 528, Amanora Chambers

Magarpatta Road, Hadapsar,

Pune – 411028

Maharashtra, India

Phone: +1 646 845 9312

Email: sales@marketresearchfuture.com

Cone Rod Dystrophy Market to Witness Widespread Expansion During 2020 to 2023

Market Highlights

The cone rod dystrophy, also known as cone-rod degeneration, progressive cone-rod dystrophy, and retinal cone dystrophy, is an inherited disease that causes an overtime deterioration of the retina. People with cone-rod dystrophy typically experience decreased clarity of vision followed by a loss of peripheral vision and color blindness. The most common form of cone-rod dystrophy is retinitis pigmentosa.

Increasing age is also one of the major factors for causing ophthalmic complications. A number of changes in the eye muscles and nerves occur as the age increase. According to WHO, 82% of people living with blindness are aged 50 and above. Some ophthalmologists believe that treatment with high doses of Vitamin A can slow the progression. Increased risk of genetic inheritance and increasing geriatric population are the key factors driving the growth of the global cone rod dystrophy market during the forecast period.

Browse Sample of the Report @ https://www.marketresearchfuture.com/sample_request/5262

Regional Analysis

Global cone rod dystrophy consists of regions namely the Americas, Europe, Asia Pacific, and the Middle East.

The Americas hold the second largest share of the global cone rod dystrophy therapy market owing to the growing incidence of eye disorders. According to National Eye Institute (NEI), blindness or low vision will affect more than 5.5 million Americans age 40 and over by 2020.

The European market dominated the global cone rod dystrophy market owing to the high prevalence rate of this disease in the Germany and Italy and other Western European countries. The European market is anticipated to compete with the American market during the forecasted period 2017-2023. Target 5000 is a Fighting Blindness research project which aims to provide genetic testing for an estimated 5,000 people in Ireland who are diagnosed with any inherited retinal condition. The purpose of this project is to provide a precise diagnosis and more detailed information about the nature and inheritance pattern of the condition.

The Asia Pacific is expected to be the fastest growing region in the global cone rod dystrophy market.

Segmentation

The cone rod dystrophy is segmented on the basis of diagnosis, treatment, and end-users.

On the basis of the diagnosis, the market is segmented into Electroretinogram (ERG), clinical history, fundus examination, molecular diagnosis, and others.

On the basis of the treatment, the market is segmented into tinted lenses/ dark sunglass, medications, magnifying devices, and surgery. The medication is classified into vitamin A supplement and anticonvulsant.

On the basis of the end-user, the market is segmented into hospitals, ophthalmic centers, research organizations, and academic institutes.

Key Players

Some of key the players in the global cone rod dystrophy market are GlaxoSmithKline Plc (U.S.), Johnson & Johnson (U.S.), Sanofi (Switzerland), Pfizer Inc. (U.S.), Novartis AG (Switzerland), Abbott Laboratories (U.S.), Sunovion Pharmaceuticals (U.S.), Cephalon (U.S.), DSM (India), Amway (U.S.), Vitamin Shoppe (U.S.), Intas Pharmaceutials Limited (India), Sun Pharmaceuticals Ltd. (India) Emcure Pharmaceuticals Limited (India), Nutrilite (U.S.), NutraScience Labs (U.S.), and others.

FOR MORE DETAILS – https://www.marketresearchfuture.com/reports/cone-rod-dystrophy-market-5262

About US:

Contact Us:

Market Research Future

Office No. 528, Amanora Chambers

Magarpatta Road, Hadapsar,

Pune – 411028

Maharashtra, India

Phone: +1 646 845 9312

Email: sales@marketresearchfuture.com

Global Geographic Tongue Market Expected to Grow with a healthy CAGR

Market Highlights

Geographic tongue is characterized by the tongue inflammation and is marked by the absence of papillae, which are small bumps present under normal conditions. General discomfort of the tongue or mouth, soreness or a burning sensation of the tongue are some of the common symptoms for the disease. Increasing prevalence of the psoriasis and growing geriatric population are some of the major drivers for the market growth. Additionally, growing oral healthcare expenditures are estimated to fuel the market growth during the forecast period. However, lack of awareness, limited availability of the treatment procedures and low per capita healthcare expenditure in the middle and low income countries are some of the restraining factor for the market growth.

The Global Geographic Tongue treatment Market is expected to grow at an approximate CAGR of 10.6% during the forecast period.

Browse Sample of the Report @ https://www.marketresearchfuture.com/sample_request/5230

Segmentation

The Global Geographic Tongue Market is segmented on the basis of diagnosis, treatment, and end user.

On the basis of the diagnosis, the market is segmented into physical examinations, biopsy, tests, and others. The tests segment is sub-segmented into vitamin B testing, HLA B antigen testing, and others.

On the basis of the treatment, the market is segmented into topical corticosteroids, zinc supplements, topical anesthetic, and others.

On the basis of the end user, the market is segmented into hospitals & clinics, research organization, diagnostic labs, and others

Regional Analysis

America dominates the global geographic tongue market. Factors such as the presence of a developed healthcare sector, rising patient population for diseases like psoriasis, increasing per capita healthcare expenditure are the major drivers for the market growth within the region. Moreover, the presence of the key players within the region boosts the market growth during the forecast period.

Europe holds the second largest market for geographic tongue owing to the rising research and developments in healthcare sector, increasing government funding and presence of huge patient population.

Asia Pacific region is the fastest growing market. Rising healthcare expenditures, developing pharmaceutical & biotechnological sector and growing geriatric population are the major drivers for the market growth within the region.

On the other hand, the Middle East & Africa hold the least share in the global geographic tongue market. Absence of the developed healthcare services, especially in the African Region restrains the market growth within the region.

Key Players

Quest Diagnostics (U.S.), Sonic Healthcare (Australia), Merck KGaA (Germany), Jost Chemical Co. (U.S.), Pfizer Inc. (U.S.), AstraZeneca (U.S.), F. Hoffmann-La Roche Ltd (Switzerland), Abbott (U.S.), Danaher (U.S.) and others are some of the key players in the global geographic tongue market.

FOR MORE DETAILS –https://www.marketresearchfuture.com/reports/geographic-tongue-market-5230

About US:

Contact Us:

Market Research Future

Office No. 528, Amanora Chambers

Magarpatta Road, Hadapsar,

Pune – 411028

Maharashtra, India

Phone: +1 646 845 9312

Email: sales@marketresearchfuture.com

North America CBCT Dental Imaging Market is expected to rise at a remarkable CAGR By 2023

Market Scenario

Over the past few years in the field of dentistry, radiographic imaging has evolved from a conventional two-dimensional technique to a three-dimensional modality. CBCT has been referred to as the gold standard and standard of care for diagnostic maxillofacial imaging. There has been increasing references in the dental literature towards the utility of cone beam computerized tomography (CBCT) in clinical dental practice.
Dental cone beam computed tomography (CT) is a special type of X-ray equipment used when regular dental or facial X-rays are not sufficient. The technology is used to produce three dimensional (3-D) images of the teeth, soft tissues, nerve pathways, and bone in a single scan. The CBCT dental imaging industry is growing rapidly. The increasing use of 3D radiographic imaging in orthodontics and increasing adoption of CBCT imaging by dental professionals has boosted the revenue of this market.

Browse Sample of the Report @ https://www.marketresearchfuture.com/sample_request/5320

The North America CBCT dental imaging market is expected to reach USD 360.44 million in the year 2023 from USD 172.31 million in 2016. The market is expected to grow at CAGR of 11.1% for the forecasted period. The major factors influencing the growth of the market include rising prevalence of dental disorders such as malocclusion, rising expenditure on dental services and procedures, rising trend of cosmetic dentistry among others. With these drivers, there are few factors hampering the growth of the market such as the risk of ionizing radiations for children and teens.

Intended Audience:

Medical Device Manufacturers
Medical Device Distributors
Hospitals & Dental clinics
Research and Development (R&D) Companies
Potential Investors

Key Players in the North Americas CBCT dental imaging Market

Some of the major players in this market are Carestream Health (U.S.), Dentsply Sirona (U.S.), FONA Dental, S.R.O. (Slovak Republic), Gendex (U.S.), Imaging Sciences International, LLC (U.S.), J. Morita MFG.CORP. (Japan), KaVo Dental GmbH (Germany), NewTom (Italy), Planmeca OY (Finland), Prexion (U.S.), Sinclair Dental/Dentaire (Canada), SOREDEX (Finland), Vatech Networks (Republic of Korea), Cefla North America (U.S.), Owandy Radiology (France), Villa Radiology Systems (Italy) Danaher Corporation (U.S.), Hitachi Medical Systems (Japan), and others

Segmentation

The North Americas CBCT dental imaging market is segmented on the basis of patient positioning, detector type, application and by the end user.

On the basis of patient positioning, the market is segmented into standing, sitting, and supine.

Based on the detector type, the market is segmented into flat panel detector and image intensifier

On the basis of application, the market is segmented into implantology, orthodontics, endodontics, and others

On the basis of the end user, it is segmented into hospitals & clinics, research centers, and others.

Regional AnalysisThe North American CBCT dental imaging market is growing at a steady pace. Globally North America contributed the largest share to the CBCT dental imaging market owing to continuously increasing demand for the medical devices, increasing a number of dental organization, the presence of major manufacturers and the presence of huge patient population. Moreover, increase in dental spending is projected to fuel the North Americas market.

The North America CBCT dental imaging market is segmented based on two major countries including the U.S. and Canada. The U.S. accounted for the largest share in the North America CBCT dental imaging market with around 85.07% of market share with a value of USD 146.58 million in 2016. The increasing cases of dental disorders, rising expenditure on dental services and procedures, high occurrence of ENT disorders, increasing number of orthopedic disorders & sports injuries, growing consciousness of CBCT systems through conferences and symposia, and presence of a large number of noticeable players in this country are the major driving factors for the U.S. CBCT dental imaging market.

Risk of ionizing radiations for children, old people and sensitive individuals is the major factor restraining the market growth in North America. Day by day advancements in technology and demand for safe products may raise the question on the current technology and lead to more advanced and friendly technique which can act as a threat to the market.

FOR MORE DETAILS – https://www.marketresearchfuture.com/reports/north-america-cbct-dental-imaging-market-5320

About US:

Contact Us:

Market Research Future

Office No. 528, Amanora Chambers

Magarpatta Road, Hadapsar,

Pune – 411028

Maharashtra, India

Phone: +1 646 845 9312

Email: sales@marketresearchfuture.com

Dietary supplements Market Estimated to Witness a Staggering Growth by 2023

Market Scenario:

Historically, dietary supplements marketing has focused on promoting a specific specialty ingredient targeted at specific consumer health needs such as omega 3 for heart health, lutein for eye care and others. Personalized nutrition offers manufacturers, the chance to develop a relationship with consumers rather than a single transactional approach. Massive advancements in the dietary supplements preparation in the field of personalized nutrition along with the possibility of the superior drug formulation will uplift the U. S. dietary supplements in the age of personalized nutrition market. The economies of scale and scope resulting out of greater demand for dietary supplements is expected to significantly reduce the final price of the products thus benefiting the final consumers. Thus, increasing the prevalence of cancer and metabolic diseases will result in arise in the volume of the dietary supplements market.

Dietary supplements in an age of personalized nutrition is regarded as one of the most noteworthy changes in the healthcare sector because of its capability to provide improved drug delivery and better patient/individual treatment process. Massive advancements in the dietary supplements preparation in the field of personalized nutrition along with the possibility of the superior drug formulation will uplift the U. S. dietary supplements in the age of personalized nutrition market.

Get Sample Copy @ https://www.marketresearchfuture.com/sample_request/5644

However, spurious and misbranded products and safety concerns of dietary supplements affect the growth of the U. S. dietary supplements in the age of personalized nutrition market negatively.

The U. S. dietary supplements in the age of personalized nutrition market is expected to grow at a CAGR of 7.95% during the forecast period 2017-2023.

Intended Audience:

Dietary Supplements Manufacturers
Research and Development (R&D) Companies
Market Research and Consulting Service Providers
Potential Investors

Segmentation

The U. S. dietary supplements in the age of personalized nutrition market is segmented by product category, application, gender, dosage form and end-user.

By the product category, it is segmented into vitamins, herbs & botanicals, sports supplements, meal supplements, minerals and other.

By the application, it is segmented into lifestyle diseases, inherited diseases, genetic predispositions and others.

By the gender, it is segmented into female and male. Female and male is further segmented into various age groups, namely, 55 + age group, 35-54 age group, 19-34 age group, and 0-18 age group.

By the dosage form, it is segmented into tablets, capsules, powder, liquids, soft gels and others.

By the end-users, it is segmented into hospitals & clinics, home care, and others.

Key Findings

The U. S. dietary supplements in the age of personalized nutrition market was USD 18,093.1 million in 2016
Vitamins is the largest segment, by product category which is projected to grow at a CAGR of 8.37% during the forecast period from 2017-2023
Female is the largest segment, by gender in S. and expected to grow at a rate of CAGR 8.45% during the forecast period
The tablets segment accounted for the largest market share with 28.3% for the U.S. dietary supplements in the age of personalized nutrition market by dosage and is expected grow with the CAGR of 8.44% for the forecast period.

TABLE OF CONTENTS

1 REPORT PROLOGUE

2 MARKET INTRODUCTION

2.1 Introduction 12

2.2 Scope Of Study 12

2.3 Research Objective 12

2.4 Assumptions & Limitations 13

2.4.1 Assumptions 13

2.4.2 Limitations 13

3 RESEARCH METHODOLOGY

3.1.1 Primary Research Methodology 16

3.1.2 Secondary Research Methodology 16

3.1.3 Market Share Analysis 17

3.1.4 Market Pricing Approach 17

4 MARKET DYNAMICS

4.1 Introduction 19

4.2 Drivers 20

4.2.1 Growing Demand For Health And Wellness Products (Impact Weightage – 45 %) 20

4.2.2 Increasing Awareness And Incidence Of Lifestyle-Related Diseases And Growing Aging Population (Impact Weightage – 35 %) 21

4.2.3 Increasing Urbanization, Rising Income And GDP, And Consumerism (Impact Weightage – 20 %) 22

4.3 Restraints 23

4.3.1 Spurious And Misbranded Products (Impact Weightage - 35 %) 23

4.3.2 Safety Concerns Of Dietary Supplements (Impact Weightage - 65 %) 24

4.4 Opportunities

Key Players

Some of the key players in this market are Nestlé Health Science, Danone Nutricia, Carlyle Group, Amway (Nutrilite), Archer Daniels Midland, Abbott Laboratories, Herbalife International, Amway, Danisco, Glanbia, Bayer AG, GlaxoSmithKline plc, Pfizer Inc., Balchem Corporation, Natures Product Inc., Bactolac Pharmaceutical Inc. and others.

FOR MORE DETAILS – https://www.marketresearchfuture.com/reports/u-s-dietary-supplements-market-5644

Biopreservation Worldwide Market Research Report 2020

Market Highlights

Biopreservation plays an important role in healthcare and food industry. It helps to preserve the biological product or material. It uses natural flora of biological material or the products of natural flora to preserve the product. The increasing expenditure on healthcare, a growing number of in vitro fertilization (IVF) centers, increasing awareness about stem cell and its applications are the major factors driving the growth of the global biopreservation market size. Additionally, increasing R&D spending and aggressive strategies adopted by the top players, such as mergers and acquisitions are contributing to the growth of the market. For instance, in March 2016, Shanghai Genext Medical Technology Co Ltd announced the acquisition of a US-based Lifeline Scientific for USD 87.8 million this acquisition will help Shanghai Genext Medical Technology to enter into the clinical transplant business.

Browse Sample of the Report @ https://www.marketresearchfuture.com/sample_request/6407

The high cost associated with biopreservation instruments and its maintenance, stability issues related to the specimen and lack of skilled personnel for handling the biopreservation process may hamper the growth of the market during the assessment period.

Regional Analysis

The market in the Americas is expected to dominate the global biopreservation market during the forecast period owing to the increasing organ transplantation, increasing healthcare expenditure, and well-established healthcare sector in the region. The European market is expected to be the second-largest due to government funding and support of the healthcare sector and an increasing number of births and with-it continuous increase in demand for umbilical cord preservation. Moreover, the market in Asia-Pacific is anticipated to be the fastest-growing during the forecast period owing to technological development, increasing awareness about stem cell and its applications, and favorable government initiatives for healthcare facilities. The market in the Middle East & Africa is likely to account for the smallest share of the global biopreservation market. The market growth in this region can be attributed to increasing healthcare expenditure and technological advancement in the region.

Segmentation

The global biopreservation market has been segmented on the basis of product, biospecimen, and application.

On the basis of product, the market has been classified as media and equipment. The media subsegment has been further divided into nutrient media, sera, and growth factors and supplements. The equipment segment has been further divided into temperature control systems, accessories, alarms & monitoring systems, incubators, centrifuges, and other equipment. The temperature control systems segment has been further classified as freezers, cryogenic storage systems, thawing equipment, and refrigerators. The biospecimen segment has been divided into human tissue samples, organs, stem cells, and other biospecimens.

The market, by source, has been segmented into regenerative medicine, biobanking, and drug discovery. On basis of regenerative medicine, the market has been divided into cell therapy, gene therapy, and others. Biobanking segment includes human egg, human sperm, and veterinary IVF.

Key Players

Some of the key players in the global biopreservation market are Thermo Fisher Scientific, Inc, VWR International, LLC., CUSTOM BIOGENIC SYSTEMS., BioLifeSolutions Inc., BioCision, Sigma-Aldrich Co., QIAGEN, Lifeline Scientific, Cesca Therapeutics Inc., Core Dynamics, Ltd., Princeton CryoTech, Biomatrica, Inc., Panasonic Biomedical, Inc., Chart Industries, and ATLANTA BIOLOGICALS

FOR MORE DETAILS – https://www.marketresearchfuture.com/reports/biopreservation-market-6407

Hemangioblastoma Market – A market with high CAGR and return on investment by 2023

The global hemangioblastoma market is expected to grow at the rate of 6.1% during the forecast period (2018–2023)

Hemangioblastoma is a type of brain tumor, it is rare and slow growing disease. Uncontrolled growth occurs in the cell linings of blood vessels and it leads to a tumor. The disease-causing factor is unknown, but it is more likely to affect people with von Hippel-Lindau disease history or it can be sporadically. The growing awareness about cancer, increasing number of tumor surgeries, growing demand for advanced therapies and increasing healthcare expenditure are expected to drive the growth of the market. According to National Center for Biotechnology Information, US National Library of Medicine, 80% cases of hemangioblastoma are sporadic, whereas 20 to 25% develop in the context of Von Hippel–Lindau disease and it accounts for 7 to 10% of total brain tumor cases.

The rising cost of tumor treatment and scarcity of experts may hamper the growth of the market during the assessment period.

Browse Sample of the Report @ https://www.marketresearchfuture.com/sample_request/6404

Regional Analysis

The market in the Americas is expected to dominate the global hemangioblastoma market during the forecast period owing to the increasing prevalence of cancer along with the increasing healthcare expenditure, and well-established healthcare sector in the region. According to the American Cancer Society, there will be an estimated 1,735,350 new cancer cases diagnosed and 609,640 cancer deaths in the United States. The European market is expected to be the second-largest due to government funding and support of the healthcare sector, and technological advancement in the region. Germany is the most affected country in the region and it has the highest number of cancer patients. Moreover, the market in Asia-Pacific is anticipated to be the fastest-growing during the forecast period owing to technological development, an increasing number of chronic diseases, and favorable government initiatives for healthcare facilities. Asia-Pacific region has a large number of patients and it can provide opportunities for the major players in the market. The market in the Middle East & Africa is likely to account for the smallest hemangioblastoma market share of the global market.

Segmentation

The global hemangioblastoma market has been segmented on the basis of tumor site, diagnosis, and treatment.

On the basis of the tumor site, the market has been classified as brain tumor, spinal cord tumor, and retinal tumor. A brain tumor is most common in all the three segments. The diagnosis segment has been classified as CT scan, MRI scan, and angiogram. According to the stage of cancer, experts can ask for multiple diagnostic tests.

The market, by treatment, has been segmented into surgery, chemotherapy, radiotherapy, corticosteroids, and anticonvulsants. Radiotherapy segment has been classified into conformal radiotherapy, intensity modulated radiotherapy (IMRT), stereotactic radiotherapy and radiosurgery. Corticosteroid segment has been further divided into hydrocortisone, dexamethasone, methylprednisolone, and prednisolone. Anticonvulsants segment has been further divided into carbamazepine, lamotrigine, levetiracetam, phenytoin, and sodium valproate.

Key Players

Some of the key players in the global hemangioblastoma market are Eli Lilly and Company, Bedford Laboratories, Astellas US Holding, Inc., DNAtrix, Inc., Advantagene, Inc., Burzynski Research Institute, Inc., Direct Therapeutics, Inc., Cellectar Biosciences, Inc., and others.

FOR MORE DETAILS – https://www.marketresearchfuture.com/reports/hemangioblastoma-market-6404